Purpose
|
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor.
|
Characteristics
|
Target: Estrogen/Progestogen Receptor antagonist Receptor: Estrogen/progestogen Receptor
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C32H47F5O3S
|
Solubility
|
DMSO 121mg/mL ,Water <1mg ml,="" ethanol="" 121mg="" ml="" <="" td="">
1mg> |